Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR

Molecular Therapy Methods and Clinical Development

Volumn 3, Issue , 2016, Pages 16019-

  D'Costa, Susan ^a   Blouin, Veronique ^b   Broucque, Frederic ^b   Penaud Budloo, Magalie ^b   Fçranois, Achille ^b   Perez, Irene C ^a   Le Bec, Christine ^c   Moullier, Philippe ^b,d   Snyder, Richard O ^a,b,d   Ayuso, Eduard ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITÉ DE NANTES   (France)

^c GÉNÉTHON   (France)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; PLASMID DNA;

ANIMAL CELL; ARTICLE; INSECT CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TITRIMETRY; VIRUS GENOME; ADENO ASSOCIATED VIRUS; COPY NUMBER VARIATION; DNA TEMPLATE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; GENOME ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INVERTED TERMINAL REPEAT; PATIENT SAFETY; PRODUCT SAFETY; VIRUS RECOMBINANT;

EID: 85015198715     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2016.19     Document Type: Article

References (28)

1. 1 Nathwani, AC, Tuddenham, EG, Rangarajan, S, Rosales, C, McIntosh, J, Linch, DC, et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365 (2011), 2357–2365.
2. 2 LeWitt, PA, Rezai, AR, Leehey, MA, Ojemann, SG, Flaherty, AW, Eskandar, EN, et al. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10 (2011), 309–319.
3. 3 Maguire, AM, High, KA, Auricchio, A, Wright, JF, Pierce, EA, Testa, F, et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 374 (2009), 1597–1605.
4. 4 Bryant, LM, Christopher, DM, Giles, AR, Hinderer, C, Rodriguez, JL, Smith, JB, et al. Lessons learned from the clinical development and market authorization of Glybera. Hum Gene Ther Clin Dev 24 (2013), 55–64.
5. 5 Lock, M, McGorray, S, Auricchio, A, Ayuso, E, Beecham, EJ, Blouin-Tavel, V, et al. Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther 21 (2010), 1273–1285.
6. 6 Ayuso, E, Blouin, V, Lock, M, McGorray, S, Leon, X, Alvira, MR, et al. Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material. Hum Gene Ther 25 (2014), 977–987.
7. 7 Moullier, P, Snyder, RO, International efforts for recombinant adeno-associated viral vector reference standards. Mol Ther 16 (2008), 1185–1188.
8. 8 Rohr, UP, Wulf, MA, Stahn, S, Steidl, U, Haas, R, Kronenwett, R, Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J Virol Methods 106 (2002), 81–88.
9. 9 Gavin, DK, FDA statement regarding the use of adeno-associated virus reference standard materials. Hum Gene Ther Methods, 26, 2015, 3.
10. 10 Werling, NJ, Satkunanathan, S, Thorpe, R, Zhao, Y, Systematic Comparison and Validation of Quantitative Real-Time PCR Methods for the Quantitation of Adeno-Associated Viral Products. Hum Gene Ther Methods 26 (2015), 82–92.
11. 11 Aurnhammer, C, Haase, M, Muether, N, Hausl, M, Rauschhuber, C, Huber, I, et al. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Hum Gene Ther Methods 23 (2012), 18–28.
12. 12 Manno, CS, Pierce, GF, Arruda, VR, Glader, B, Ragni, M, Rasko, JJ, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12 (2006), 342–347.
13. 13 Fagone, P, Wright, JF, Nathwani, AC, Nienhuis, AW, Davidoff, AM, Gray, JT, Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods. Hum Gene Ther Methods 23 (2012), 1–7.
14. 14 Wang, F, Cui, X, Wang, M, Xiao, W, Xu, R, A reliable and feasible qPCR strategy for titrating AAV vectors. Med Sci Monit Basic Res 19 (2013), 187–193.
15. 15 Samulski, RJ, Chang, LS, Shenk, T, Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 63 (1989), 3822–3828.
16. 16 Ayuso, E, Mingozzi, F, Montane, J, Leon, X, Anguela, XM, Haurigot, V, et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther 17 (2010), 503–510.
17. 17 Hou, Y, Zhang, H, Miranda, L, Lin, S, Serious overestimation in quantitative PCR by circular (supercoiled) plasmid standard: microalgal pcna as the model gene. PLoS One, 5, 2010, e9545.
18. 18 Lock, M, Alvira, MR, Chen, SJ, Wilson, JM, Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR. Hum Gene Ther Methods 25 (2014), 115–125.
19. 19 Sanders, R, Huggett, JF, Bushell, CA, Cowen, S, Scott, DJ, Foy, CA, Evaluation of digital PCR for absolute DNA quantification. Anal Chem 83 (2011), 6474–6484.
20. 20 Piedra, J, Ontiveros, M, Miravet, S, Penalva, C, Monfar, M, Chillon, M, Development of a rapid, robust, and universal picogreen-based method to titer adeno-associated vectors. Hum Gene Ther Methods 26 (2015), 35–42.
21. 21 Bustin, SA, Benes, V, Garson, JA, Hellemans, J, Huggett, J, Kubista, M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55 (2009), 611–622.
22. 22 Gao, K, Li, M, Zhong, L, Su, Q, Li, J, Li, S, et al. Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side-effects. Mol Ther Methods Clin Dev, 1, 2014, 20139.
23. 23 Mingozzi, F, Anguela, XM, Pavani, G, Chen, Y, Davidson, RJ, Hui, DJ, et al. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci Transl Med, 5, 2013, 194ra92.
24. 24 Mingozzi, F, Maus, MV, Hui, DJ, Sabatino, DE, Murphy, SL, Rasko, JE, et al. CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med 13 (2007), 419–422.
25. 25 Walsh, CE, Liu, JM, Xiao, X, Young, NS, Nienhuis, AW, Samulski, RJ, Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci USA 89 (1992), 7257–7261.
26. 26 Burger, C, Gorbatyuk, OS, Velardo, MJ, Peden, CS, Williams, P, Zolotukhin, S, et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10 (2004), 302–317.
27. 27 Smith, RH, Levy, JR, Kotin, RM, A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol Ther 17 (2009), 1888–1896.
28. 28 Urabe, M, Ding, C, Kotin, RM, Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 13 (2002), 1935–1943.